| Effects of flaxseed oil supplementation on metaphase II oocyte rates in IVF cycles with decreased ovarian reserve: a randomized controlled trial 2024 · study group · Women aged 40 or younger with decreased ovarian reserve undergoing IVF/ICSI | 1 g | — | 128 |
| [Oral flaxseed oil (Linum usitatissimum) in the treatment for dry-eye Sjögren's syndrome patients] 2007 · Group I · Female patients with rheumatoid arthritis or systemic lupus erythematosus associated with keratoconjunctivitis sicca and Sjögren's syndrome | 1 g | 180 days | 13 |
| [Oral flaxseed oil (Linum usitatissimum) in the treatment for dry-eye Sjögren's syndrome patients] 2007 · Group II · Female patients with rheumatoid arthritis or systemic lupus erythematosus associated with keratoconjunctivitis sicca and Sjögren's syndrome | 2 g | 180 days | 12 |
| The short-term effects of olive oil and flaxseed oil for the treatment of constipation in hemodialysis patients 2015 · flaxseed oil · Adults with constipation undergoing hemodialysis; mean age 51 ± 12 years, 29% male | 4 mL | 4 weeks | 17 |
| Supplementation with Flaxseed Oil Rich in Alpha-Linolenic Acid Improves Verbal Fluency in Healthy Older Adults 2023 · ALA group · Healthy right-handed men and women aged 65–80 years without cognitive impairment | 3.7 g | 12 weeks | 30 |
| Effects of diacylglycerol-enriched alpha-linolenic acid oil on skin properties in mild skin discomfort: a randomized, double-blind, placebo-controlled study 2026 · ALA-DAG group · Men and women aged 20–59 with mild subjective skin discomfort and occasional allergy-like symptoms, without a clinical diagnosis of allergic disease | 2.5 g | 8 weeks | 30 |
| Effect of α-linolenic acid on vascular function and metabolic risk markers during the fasting and postprandial phase: A randomized placebo-controlled trial in untreated (pre-)hypertensive individuals 2020 · Flaxseed oil · Overweight and obese adults aged 60 ± 8 years with high-normal blood pressure or mild (stage I) hypertension | 10 g | 12 weeks | 29 |
| Clinical Assessment of Efficacy of Omega 3 in Oral Submucous Fibrosis Patients - A Randomized Controlled Trial 2022 · Group B · Adults aged 19–52 with grade II or III oral submucous fibrosis; all consumed areca nut | 6 mL | 90 days | 24 |
| Lowering Effects of n-3 Fatty Acid Supplements on Blood Pressure by Reducing Plasma Angiotensin II in Inner Mongolia Hypertensive Patients: A Double-Blind Randomized Controlled Trial 2019 · flaxseed oil group · Chinese adults with hypertension from Inner Mongolia; age range and sex not specified | 2.5 g | — | 42 |
| Dietary supplementation with flaxseed oil lowers blood pressure in dyslipidaemic patients 2007 · flaxseed oil group · Middle-aged men with dyslipidaemia | 8 g | 12 weeks | 31 |
| Comparison of the effects of flaxseed oil and sunflower seed oil consumption on serum glucose, lipid profile, blood pressure, and lipid peroxidation in patients with metabolic syndrome 2018 · FO group · Adults aged 30 to 60 years with metabolic syndrome | 25 mL | 7 weeks | 30 |
| Flaxseed oil and fish-oil capsule consumption alters human red blood cell n-3 fatty acid composition: a multiple-dosing trial comparing 2 sources of n-3 fatty acid 2008 · 1.2 g flax oil/d · Firefighters exposed to cardiovascular disease risk factors; age and sex not stated | 1.2 g | 12 weeks | — |
| The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial 2018 · flaxseed oil omega-3 fatty acids group · Women aged 18–40 years with polycystic ovary syndrome | 2 g | 12 weeks | 30 |
| Flaxseed oil supplementation decreases C-reactive protein levels in chronic hemodialysis patients 2012 · flaxseed oil group · Patients with chronic renal failure receiving hemodialysis | 2 g | 120 days | — |
| Inflammation markers predict zinc transporter gene expression in women with type 2 diabetes mellitus 2013 · ALA (flaxseed oil) · postmenopausal women with type 2 diabetes mellitus | 2 g | 12 weeks | — |
| Effects of marine-derived and plant-derived omega-3 polyunsaturated fatty acids on erythrocyte fatty acid composition in type 2 diabetic patients 2022 · LFO (mixed linseed oil and fish oil) group · Adults aged 18–70 with type 2 diabetes and dyslipidemia | 1.5 g | 26 weeks | 48 |
| Cheek cell fatty acids reflect n-3 PUFA in blood fractions during linseed oil supplementation: a controlled human intervention study 2013 · Test group – linseed oil mix · Healthy adults from the general population, men and women, BMI <25; ages ranged from 18 to 59 years | 17 g | 8 weeks | 23 |
| Supplementation with flaxseed oil versus sunflowerseed oil in healthy young men consuming a low fat diet: effects on platelet composition and function 1995 · flaxseed oil · healthy young men | 40 g | 23 days | 5 |
| Effects of fish-oil supplementation on myocardial fatty acids in humans 2007 · flaxseed oil · Patients with low self-reported fish intake accepted for elective cardiac surgery involving cardiopulmonary bypass | 10 mL | 3 weeks | — |
| Intervention with flaxseed and borage oil supplements modulates skin condition in women 2009 · flaxseed oil group · Women; age range and health condition not specified | 2.2 g | 12 weeks | — |
| Flaxseed oil and fish-oil capsule consumption alters human red blood cell n-3 fatty acid composition: a multiple-dosing trial comparing 2 sources of n-3 fatty acid 2008 · 2.4 g flax oil/d · Firefighters exposed to cardiovascular disease risk factors; age and sex not stated | 2.4 g | 12 weeks | — |
| Flaxseed oil and fish-oil capsule consumption alters human red blood cell n-3 fatty acid composition: a multiple-dosing trial comparing 2 sources of n-3 fatty acid 2008 · 3.6 g flax oil/d · Firefighters exposed to cardiovascular disease risk factors; age and sex not stated | 3.6 g | 12 weeks | — |
| Replication of a Gene-Diet Interaction at CD36, NOS3 and PPARG in Response to Omega-3 Fatty Acid Supplements on Blood Lipids: A Double-Blind Randomized Controlled Trial 2018 · flaxseed oil group · Adults aged 35–80 years (women postmenopausal), with type 2 diabetes | 2.5 g | 180 days | 61 |
| The effect of diet enriched with alpha-linolenic acid on soluble cellular adhesion molecules in dyslipidaemic patients 2004 · linseed oil group · Dyslipidaemic men, mean age 51 ± 8 years | 15 mL | 12 weeks | 60 |
| Additive effect of linseed oil supplementation on the lipid profiles of older adults 2015 · linseed oil + nutritional guidelines group (LG) · Adults aged 60 years or older; older adults, with no single diagnosed condition required for inclusion | 3 g | 90 days | 57 |
| Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients 2003 · linseed oil group · Men with dyslipidaemia, mean age 51 years | 15 mL | 90 days | 50 |
| Serum metabolomics profiles in response to n-3 fatty acids in Chinese patients with type 2 diabetes: a double-blind randomised controlled trial 2016 · flaxseed oil (FSO) · Chinese adults aged 35–80 years with type 2 diabetes; men aged 35–80 and post-menopausal women up to age 80 | 2.52 g | 180 days | 20 |
| Flaxseed oil intake reduces serum small dense low-density lipoprotein concentrations in Japanese men: a randomized, double blind, crossover study 2015 · Flaxseed oil period · Adult men, mean age 44.5 years, described as healthy; some were smokers or receiving antihypertensive drugs | 10 g | 12 weeks | 15 |
| Effects of hempseed and flaxseed oils on the profile of serum lipids, serum total and lipoprotein lipid concentrations and haemostatic factors 2006 · flaxseed oil (FO) period · 14 healthy volunteers; age and sex not specified | 30 mL | 4 weeks | 14 |
| Effects of dietary oleic, linoleic and alpha-linolenic acids on blood pressure, serum lipids, lipoproteins and the formation of eicosanoid precursors in patients with mild essential hypertension 1990 · linseed oil group · Male in-patients with mild essential hypertension | 60 mL | 2 weeks | 14 |
| Short-term carnitine supplementation does not augment LCPomega3 status of vegans and lacto-ovo-vegetarians 2005 · Group B, weeks 1–4 · Apparently healthy vegans and lacto-ovo-vegetarians | 4 mL | 4 weeks | 9 |
| Flaxseed oil supplementation increases plasma F1-phytoprostanes in healthy men 2009 · Flaxseed oil group · Men aged 20–65 years recruited from the general population; healthy, nonsmoking | 9 g | 4 weeks | — |
| Flaxseed oil does not affect inflammatory markers and lipid profile compared to olive oil, in young, healthy, normal weight adults 2013 · Flaxseed oil (FO) · Young, apparently healthy, normal-weight adults | 15 mL | 6 weeks | — |
| Inflammation markers predict zinc transporter gene expression in women with type 2 diabetes mellitus 2013 · zinc plus ALA · postmenopausal women with type 2 diabetes mellitus | 2 g | 12 weeks | — |
| Effect of flaxseed oil on serum systemic and vascular inflammation markers and oxidative stress in hemodialysis patients: a randomized controlled trial 2016 · flaxseed oil group · Hemodialysis patients; age and sex not stated | 6 g | 8 weeks | — |
| Effects of flaxseed oil on blood hepcidin and hematologic factors in hemodialysis patients 2017 · flaxseed oil group · Hemodialysis patients with renal anemia; age and sex not specified | 6 g | 8 weeks | — |
| Effects of Flaxseed Oil on Serum Lipids and Lipoproteins in Hemodialysis Patients: a Randomized Controlled Trial 2016 · flaxseed oil group · Hemodialysis patients; age and sex not specified | 6 g | 8 weeks | — |
| Unsaturated Fatty Acids Improve Atherosclerosis Markers in Obese and Overweight Non-diabetic Elderly Patients 2017 · flaxseed oil · elderly obese or overweight non-diabetic patients | 30 mL | 90 days | — |
| Effects of Flaxseed Oil on Serum Bone Turnover Markers in Hemodialysis Patients: a Randomized Controlled Trial 2018 · flaxseed oil group · Hemodialysis patients with chronic kidney disease-mineral and bone disorder; age and sex not specified | 6 g | 8 weeks | — |
| Effects of flaxseed and flaxseed oil supplement on serum levels of inflammatory markers, metabolic parameters and severity of disease in patients with ulcerative colitis 2019 · flaxseed oil (FO) · Patients with ulcerative colitis; adults, mean age 31.54 ± 9.84 years; sex distribution for completers was 43 men and 32 women | 10 g | 12 weeks | — |
| Consumption of echium oil increases EPA and DPA in blood fractions more efficiently compared to linseed oil in humans 2016 · Linseed oil mixture (LO) · Adults aged 20–69 years, women and men, including normal-weight and overweight participants; no chronic disease reported | 17 g | 8 weeks | 60 |
| Effects of n-3 fatty acid supplements on glycemic traits in Chinese type 2 diabetic patients: A double-blind randomized controlled trial 2016 · flaxseed oil (FSO) group · Chinese adults with type 2 diabetes | 2.5 g | 180 days | 61 |
| Dietary oils and FADS1-FADS2 genetic variants modulate [13C]α-linolenic acid metabolism and plasma fatty acid composition 2013 · FXCO diet · Hyperlipidemic subjects; age and sex not specified | 20.6 g | 4 weeks | 36 |
| Comparing isolated soy protein with flaxseed oil vs isolated soy protein with corn oil and wheat flour with corn oil consumption on muscle catabolism, liver function, blood lipid, and sugar in burn patients: a randomized clinical trial 2018 · ISP + FO (Group A) · Patients aged 15–60 years with burns covering 20–50% of total body surface area | 30 g | 3 weeks | 25 |
| Metabolic and endocrine effects of long-chain versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome 2011 · flaxseed oil · Women aged 20–45 with PCOS and BMI 25–45 kg/m² | 3.27 g | 6 weeks | 23 |
| Dietary milled flaxseed and flaxseed oil improve N-3 fatty acid status and do not affect glycemic control in individuals with well-controlled type 2 diabetes 2010 · flaxseed oil (FXO) · Adults with well-controlled type 2 diabetes; mean age 52.4 years; men and women | 13 g | 12 weeks | 12 |
| Short-term carnitine supplementation does not augment LCPomega3 status of vegans and lacto-ovo-vegetarians 2005 · Group A, weeks 5–8 · Apparently healthy vegans and lacto-ovo-vegetarians | 4 mL | 4 weeks | 11 |
| Short-term carnitine supplementation does not augment LCPomega3 status of vegans and lacto-ovo-vegetarians 2005 · Group B, weeks 5–8 · Apparently healthy vegans and lacto-ovo-vegetarians | 4 mL | 4 weeks | 9 |
| Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye 2011 · omega-3 group · Patients with dry eye; age and sex not reported | 1 g | 90 days | — |